{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:01:57Z","timestamp":1773885717169,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.msard.2020.102668","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T02:58:39Z","timestamp":1606877919000},"page":"102668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder: The Experience from Saudi Arabia"],"prefix":"10.1016","volume":"47","author":[{"given":"Hussein","family":"Algahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bader","family":"Shirah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Badr","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaser Al","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seraj","family":"Makkawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.msard.2020.102668_bib0001","doi-asserted-by":"crossref","first-page":"e79649","DOI":"10.1371\/journal.pone.0079649","article-title":"Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people","volume":"8","author":"Aboul-enein","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2020.102668_bib0002","series-title":"Epidemiology of neuromyelitis optica spectrum disorders patients in Kuwait","author":"Ahmed","year":"2019"},{"issue":"1","key":"10.1016\/j.msard.2020.102668_bib0003","article-title":"Neuromyelitis optica spectrum disorders in the Arabian Gulf: challenges and growing experience","volume":"6","author":"Alroughani","year":"2020","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"8","key":"10.1016\/j.msard.2020.102668_bib0004","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of NMOSD in Australia and New Zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1-2","key":"10.1016\/j.msard.2020.102668_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2009.04.039","article-title":"Environmental changes and epidemiology of multiple sclerosis in the French West Indies","volume":"286","author":"Cabre","year":"2009","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.msard.2020.102668_bib0006","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-g\u00f3mez","year":"2009","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.msard.2020.102668_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40265-018-1039-7","article-title":"Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options","volume":"79","author":"Collongues","year":"2019","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.msard.2020.102668_bib0008","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/1352458515602337","article-title":"Efficacy of rituximab in refractory neuromyelitis optica","volume":"22","author":"Collongues","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.msard.2020.102668_bib0009","first-page":"1033","article-title":"\"My\u00e9lite subaigu\u00eb compliqu\u00e9e de n\u00e9vrite optique\" [Subacute myelitis complicated with optic neuritis]","volume":"8","author":"Devic","year":"1894","journal-title":"Bull Med (in French)"},{"key":"10.1016\/j.msard.2020.102668_bib0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Mult Scler Relat Disord"},{"issue":"3","key":"10.1016\/j.msard.2020.102668_bib0011","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen3.12458","article-title":"Prevalence and characteristics of transverse myelitis and neuromyelitis optica spectrum disorders in the United Arab Emirates: A multicenter, retrospective study","volume":"9","author":"Holroyd","year":"2018","journal-title":"Clin Exp Neuroimmunol"},{"issue":"1-2","key":"10.1016\/j.msard.2020.102668_bib0012","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.08.032","article-title":"Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan","volume":"323","author":"Houzen","year":"2012","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.msard.2020.102668_bib0013","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1007\/s00415-013-6926-y","article-title":"The epidemiology of neuromyelitis optica amongst adults in the Merseyside county of United Kingdom","volume":"260","author":"Jacob","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.msard.2020.102668_bib0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-10-8","article-title":"The history of neuromyelitis optica","volume":"10","author":"Jarius","year":"2013","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.msard.2020.102668_bib0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/CON.0000000000000337","article-title":"Neuromyelitis Optica Spectrum Disorders","volume":"22","author":"Katz sand","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"Pt 6","key":"10.1016\/j.msard.2020.102668_bib0016","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/brain\/aws109","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan","volume":"135","author":"Kitley","year":"2012","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.msard.2020.102668_bib0017","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archneurol.2012.314","article-title":"Epidemiology of neuromyelitis optica in the United States: a multicenter analysis","volume":"69","author":"Mealy","year":"2012","journal-title":"Arch Neurol"},{"issue":"7","key":"10.1016\/j.msard.2020.102668_bib0018","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: A review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.msard.2020.102668_bib0019","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: A review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.msard.2020.102668_bib0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.rdc.2017.06.007","article-title":"Neuromyelitis Optica","volume":"43","author":"Patterson","year":"2017","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.msard.2020.102668_bib0021","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jamaneurol.2014.1581","article-title":"Seroprevalence of aquaporin-4-IgG in a northern California population representative cohort of multiple sclerosis","volume":"71","author":"Pittock","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.msard.2020.102668_bib0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.msard.2015.06.003","article-title":"Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis","volume":"4","author":"Ruiz-gaviria","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2020.102668_bib0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jneuroim.2018.08.014","article-title":"Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the North Egyptian Nile Delta","volume":"324","author":"Salama","year":"2018","journal-title":"J Neuroimmunol"},{"issue":"17","key":"10.1016\/j.msard.2020.102668_bib0024","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1212\/WNL.0000000000006392","article-title":"Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD","volume":"91","author":"Shosha","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.msard.2020.102668_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11910-013-0403-y","article-title":"Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention","volume":"13","author":"Solomon","year":"2013","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9","key":"10.1016\/j.msard.2020.102668_bib0026","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica","volume":"87","author":"Waters","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.msard.2020.102668_bib0027","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis Spectrum Disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.msard.2020.102668_bib0028","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.msard.2020.102668_bib0029","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102668_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102166","article-title":"Efficacy and Safety of Monoclonal Antibody Therapy in Neuromyelitis Optica Spectrum Disorders: Evidence from Randomized Controlled Trials","volume":"43","author":"Xue","year":"2020","journal-title":"Mult Scler Relat Disord"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820307422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:51:40Z","timestamp":1761900700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820307422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":30,"alternative-id":["S2211034820307422"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102668","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Radiological Characteristics of Neuromyelitis Optica Spectrum Disorder: The Experience from Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102668"}}